As such, AHR signaling has been recognized as a key regulator of several immune diseases, however, current literature regarding the impact of AHR activation on the pathogenesis of type 1 diabetes suggests that its effect is indirect through immune modulation and not directly on beta cells. Here, AHR is linked to immune system disorder.